BRIEF published on 07/09/2024 at 12:35, 1 year 4 months ago Immunic nomme Jason Tardio au poste de directeur de l'exploitation et président Sclérose En Plaques Vidofludimus Calcium Nomination Du COO Immunitaire Jason Tardio
PRESS RELEASE published on 07/09/2024 at 12:30, 1 year 4 months ago Immunic Appoints Jason Tardio as Chief Operating Officer and President Immunic appoints Jason Tardio as Chief Operating Officer and President, bringing extensive multiple sclerosis drug commercialization experience. Werner Gladdines promoted to Chief Development Officer Chief Operating Officer Multiple Sclerosis Immunic Jason Tardio Werner Gladdines
BRIEF published on 05/28/2024 at 12:35, 1 year 6 months ago Immunic to Participate in Industry and Scientific Conferences in June Biotechnology Investor Relations Conférences Chronic Diseases Scientific Engagement
BRIEF published on 05/28/2024 at 12:35, 1 year 6 months ago Immunic participera à des conférences industrielles et scientifiques en juin Biotechnologie Conférences Relations Avec Les Investisseurs Maladies Chroniques Engagement Scientifique
PRESS RELEASE published on 05/28/2024 at 12:30, 1 year 6 months ago Immunic to Participate in Industry and Scientific Conferences in June Immunic, Inc. (Nasdaq: IMUX) will participate in BIO International Convention 2024 and PCMG Assembly 2024 in June to present clinical pipeline of therapies for chronic inflammatory and autoimmune diseases Clinical Pipeline Immunic Inc IMUX BIO International Convention 2024 PCMG Assembly 2024
BRIEF published on 05/08/2024 at 12:35, 1 year 6 months ago Immunic, Inc. Announces Q1 2024 Financial Results and Corporate Updates Financial Strategy Immunic Inc Q1 2024 Financial Report Multiple Sclerosis Trials Celiac Disease Treatment
BRIEF published on 05/08/2024 at 12:35, 1 year 6 months ago Immunic, Inc. annonce ses résultats financiers du premier trimestre 2024 et des mises à jour sur l'entreprise Stratégie Financière Immunic Inc Rapport Financier Du Premier Trimestre 2024 Essais Sur La Sclérose En Plaques Traitement De La Maladie Coeliaque
PRESS RELEASE published on 05/08/2024 at 12:30, 1 year 6 months ago Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update Immunic, Inc. reports first quarter 2024 financial results, including capital increase and progress in MS and gastrointestinal disease therapies Financial Results Clinical Trials Immunic Inc. Gastrointestinal Disease MS Therapy
BRIEF published on 05/06/2024 at 12:35, 1 year 6 months ago Immunic AG Announces Participation in May Conferences for Investor and Scientific Communities Investor Conferences Clinical Trials Immunic AG Scientific Conferences Autoimmune Disease Treatments
BRIEF published on 05/06/2024 at 12:35, 1 year 6 months ago Immunic AG annonce sa participation aux conférences de mai destinées aux communautés d'investisseurs et scientifiques Essais Cliniques Conférences Investisseurs Immunic SA Conférences Scientifiques Traitements Des Maladies Auto-immunes
Published on 12/05/2025 at 16:00, 20 minutes ago SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 35 minutes ago Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 35 minutes ago Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 45 minutes ago XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 16:10, 10 minutes ago Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 20 minutes ago EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 20 minutes ago EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 20 minutes ago Amundi Physical Metals plc: Communiqué de Mise à Disposition du Rapport Financier Semestriel au 30 septembre 2025
Published on 12/05/2025 at 16:00, 20 minutes ago Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 15:10, 1 hour 9 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 1 hour 9 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 2 hours 21 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 7 hours 35 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 7 hours 35 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
